MORRIS PLAINS, N.J., Sept. 17, 2018 /PRNewswire/ -- Temptime Corporation unveiled new technology today that will expandthe range and flexibility of the company's Vaccine Vial Monitors (VVMs), which monitor the temperature exposure of vaccines to ensure that they have not been compromised by excessive heat. The World Health Organization (WHO) recently identified new
Temptime expanded the VVM technology to address an increasing range of temperatures and shelf lives for new vaccines coming to market. Following three years of research and development, Temptime's scientists created the first VVM to monitor vaccines and other pharmaceutical products stored at room temperature. The company also added a new type of VVM with more specificity for monitoring refrigerated medications.
"It is an honor to support the world's leading health organizations in the delivery of new and critical medical products to people around the world," said Renaat Van den Hooff, president and CEO, Temptime. "Our company is built on innovation and this technology is another contribution toward our mission of creating new solutions that will meaningfully improve global health."
Founded in 1987, Temptime developed the first technology to monitor temperature exposure of vials containing the oral polio vaccine. Since then, the company has developed different temperature sensitivities of VVMs and grown to support the world's leading health organizations and pharmaceutical companies with safely storing and distributing a range of vaccines and medical products across the globe.
About TemptimeTemptime is the world leader in time-temperature indicators to the health care industry. The company plays a vital role in improving global health by providing solutions that monitor temperature-sensitive medical and biological products and devices. The world's largest health organizations and manufacturers use Temptime's indicators to support them with safely distributing medical products and supplies around the world. Temptime is a company of Water Street Healthcare Partners, a strategic investor focused exclusively on the health care industry. To learn more about Temptime, please visit temptimecorp.com.
View original content:http://www.prnewswire.com/news-releases/temptime-unveils-new-technology-to-support-global-health-organizations-with-medical-product-safety-300712873.html
SOURCE Temptime Corporation
Subscribe to our Free Newsletters!
FDA approved elapegademase-lvlr injection for intramuscular use is used as an enzyme replacement ...
Armpit lumps and raised bumps in the armpits caused by infection, cysts and other types of ...
Bad eating habits will affect your health as well as your skin and make you look older than your ...View All